USD 1.35
(4.65%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 44.5 Million USD | -35.98% |
2022 | 69.5 Million USD | 42.79% |
2021 | 48.67 Million USD | 19.53% |
2020 | 40.72 Million USD | -29.97% |
2019 | 58.15 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 8.4 Million USD | -14.37% |
2024 Q1 | 9.82 Million USD | 14.61% |
2023 Q1 | 14.85 Million USD | -9.01% |
2023 FY | 44.5 Million USD | -35.98% |
2023 Q3 | 10.89 Million USD | 6.94% |
2023 Q2 | 10.18 Million USD | -31.4% |
2023 Q4 | 8.56 Million USD | -21.36% |
2022 Q1 | 17.41 Million USD | 14.99% |
2022 Q4 | 16.32 Million USD | 0.15% |
2022 Q3 | 16.29 Million USD | -16.33% |
2022 FY | 69.5 Million USD | 42.79% |
2022 Q2 | 19.47 Million USD | 11.88% |
2021 FY | 48.67 Million USD | 19.53% |
2021 Q4 | 15.14 Million USD | 12.4% |
2021 Q3 | 13.47 Million USD | 27.21% |
2021 Q2 | 10.58 Million USD | 11.71% |
2021 Q1 | 9.47 Million USD | 6.91% |
2020 Q4 | 8.86 Million USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q1 | 376.33 Thousand USD | 0.0% |
2020 Q2 | - USD | -100.0% |
2020 FY | 40.72 Million USD | -29.97% |
2019 Q3 | - USD | 0.0% |
2019 FY | 58.15 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
CannBioRx Life Sciences Corp. | 13.47 Million USD | -230.195% |
BIMI International Medical Inc. | 17.28 Million USD | -157.41% |
China Jo-Jo Drugstores, Inc. | 34.64 Million USD | -28.458% |
Harrow Health, Inc. 8.625% Senior Notes due 2026 | 89.97 Million USD | 50.538% |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | 90.12 Million USD | 50.62% |
Leafly Holdings, Inc. | 44.5 Million USD | 0.0% |
LifeMD, Inc. | 148.13 Million USD | 69.959% |
LifeMD, Inc. | 148.13 Million USD | 69.959% |
TRxADE HEALTH, Inc. | 9.86 Million USD | -351.263% |
PetMed Express, Inc. | 86.81 Million USD | 48.736% |
Walgreens Boots Alliance, Inc. | 40.6 Billion USD | 99.89% |